AMG 335 Expanded Access Program for IgG4-Related Disease

Amgen

Status

Treatments: Drug: UPLIZNA

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT06590051

AMG335 Expanded Access Program

Details and patient eligibility

About

Expanded access requests for AMG 335 may be considered for adult patients with a confirmed diagnosis of IgG4-related disease. To request access, use Responsible Party contact information provided in this record.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria